NAPLEX Quiz: Health Histories And Screenings

What this quiz covers

This quiz focuses on Health Histories And Screenings, giving you a quick way to practice the rules, question types, and explanations that matter most for NAPLEX.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

Question 1

1. Recommend recombinant zoster vaccine series because it is indicated for adults aged 50 years and older, and neomycin allergy is not a contraindication (correct answer)
2. Recommend live zoster vaccine because it is preferred in adults older than 70
3. Recommend no shingles vaccination unless she has a prior shingles episode
4. Recommend shingles vaccination every year to maintain immunity

Explanation: This question tests the concept of shingles vaccination recommendations in older adults, considering allergies and vaccine types. The key patient-specific factor is age 72 with neomycin allergy (rash), but recombinant zoster vaccine does not contain neomycin and is preferred. Choice A is the best screening because recombinant zoster is indicated for adults 50+ regardless of shingles history. Choice B is incorrect as live zoster is no longer recommended; choice C is wrong because vaccination prevents primary shingles. Choice D is suboptimal as it's not annual. A clinical pearl is that recombinant zoster is safe with neomycin allergy. Vaccinate all eligible adults to reduce shingles burden.

Question 2

1. Avoid decongestants like pseudoephedrine due to risk of hypertensive crisis with monoamine oxidase inhibitors and uncontrolled blood pressure; recommend safer alternatives (e.g., saline, guaifenesin if appropriate) (correct answer)
2. Recommend pseudoephedrine 60 mg every 4–6 hours because it is safe with phenelzine when taken with food
3. Recommend dextromethorphan high-dose syrup because it has no interaction with phenelzine
4. Recommend stopping phenelzine for 2 days so she can take any cold product safely

Explanation: This question tests the concept of OTC product selection safety with monoamine oxidase inhibitors to prevent hypertensive crises. The key patient-specific factor is phenelzine use with uncontrolled hypertension, contraindicating sympathomimetics like pseudoephedrine. Choice A is the best counseling because avoiding decongestants and recommending alternatives like saline prevents interactions. Choice B is incorrect as pseudoephedrine with food does not eliminate risk; choice C is wrong because dextromethorphan can interact via serotonin. Choice D is suboptimal as stopping phenelzine risks psychiatric decompensation. A transferable pearl is that MAOIs have broad interactions with tyramine and sympathomimetics. Guide patients to non-interacting OTC options.

Question 3

1. Assess and address adverse effects (genital infections, dehydration risk), counsel on hygiene/hydration, and coordinate with prescriber on alternative therapy if needed (correct answer)
2. Tell the patient to take empagliflozin only on days when blood glucose is high to reduce infections
3. Recommend stopping lisinopril to prevent yeast infections and improve adherence to diabetes medications
4. Recommend adding an over-the-counter antifungal prophylactically without discussing ongoing symptoms or prescriber follow-up

Explanation: This question tests the concept of addressing medication nonadherence due to adverse effects in diabetes management. The key patient-specific factor is frequent genital yeast infections with empagliflozin, leading to skipped doses, and outdoor work increasing dehydration risk. Choice A is the best strategy because assessing effects, counseling on prevention, and coordinating alternatives improves adherence safely. Choice B is incorrect as PRN use is ineffective for SGLT2 inhibitors; choice C is wrong because stopping lisinopril does not address infections. Choice D is suboptimal as prophylactic antifungals without follow-up may mask issues. A transferable pearl is to proactively counsel on SGLT2i side effects like infections. Use adherence tools and prescriber collaboration for persistent issues.

Question 4

1. Begin cervical cancer screening now with a Pap test and continue at recommended intervals for her age group (correct answer)
2. Begin screening mammography now and repeat annually because she uses hormonal contraception
3. Screen for colorectal cancer now with colonoscopy and repeat every 3 years
4. Begin bone mineral density screening now and repeat every 2 years because she is underweight

Explanation: This question evaluates knowledge of age-appropriate cancer screening guidelines for young adults. The patient is a sexually active 24-year-old woman who has never had cervical cancer screening. Option A is correct because cervical cancer screening should begin at age 21 regardless of sexual activity status, and she's overdue at age 24. Option B is incorrect as screening mammography typically begins at age 40-50 depending on risk factors, and hormonal contraception doesn't change this. Option C is wrong because colorectal cancer screening begins at age 45 in average-risk individuals. Option D is inappropriate as bone density screening begins at age 65 for women without risk factors, and being normal weight doesn't warrant early screening. The key principle is that cervical cancer screening begins at age 21 for all women and continues at regular intervals regardless of sexual history or contraceptive use.

Question 5

1. Dispense trimethoprim-sulfamethoxazole as written and advise no monitoring is needed because INR was recently therapeutic
2. Contact the prescriber to recommend an alternative antibiotic or plan for closer INR monitoring and warfarin dose adjustment due to increased bleeding risk (correct answer)
3. Recommend increasing warfarin dose immediately because antibiotics reduce INR
4. Recommend stopping amiodarone for 7 days to prevent interaction with the antibiotic

Explanation: This question tests the concept of managing drug-drug interactions with warfarin, particularly antibiotics that potentiate anticoagulation. The key patient-specific factor is the new prescription for trimethoprim-sulfamethoxazole, which inhibits warfarin metabolism and increases INR/bleeding risk, especially with recent therapeutic INR of 2.4. Choice B is the best action because contacting the prescriber for alternatives or monitoring plans prevents adverse events. Choice A is incorrect as dispensing without monitoring risks bleeding; choice C is wrong because antibiotics like TMP-SMX typically increase, not reduce, INR. Choice D is suboptimal as stopping amiodarone abruptly could destabilize atrial fibrillation. A clinical pearl is to anticipate INR elevation with TMP-SMX and plan weekly monitoring. Use interaction checkers and educate patients on signs of bleeding when adding interacting drugs to warfarin.

Question 6

1. Recommend repeating HbA1c in 5 years because she is under age 50 and has no symptoms
2. Refer her to a primary care provider promptly for confirmation of diabetes and initiation of a treatment plan, including lifestyle changes and possible medication (correct answer)
3. Advise starting insulin glargine 10 units subcutaneously nightly immediately to prevent complications
4. Recommend increasing dietary fiber only and no medical follow-up until fasting glucose exceeds 200 mg/dL

Explanation: This question evaluates recognition of new-onset diabetes mellitus and metabolic syndrome requiring comprehensive management. The patient meets diagnostic criteria for diabetes (fasting glucose ≥126 mg/dL and HbA1c ≥6.5%) plus has metabolic syndrome components (elevated triglycerides, low HDL, elevated blood pressure). Option B is correct because newly diagnosed diabetes requires prompt medical evaluation to establish a comprehensive treatment plan including lifestyle modifications and potential medication therapy. Option A is incorrect as the patient already has diabetes, not prediabetes, and requires immediate intervention. Option C is inappropriate because insulin is not first-line therapy for type 2 diabetes and pharmacists cannot independently prescribe. Option D dangerously delays treatment when the patient already meets diabetes diagnostic criteria. The key principle is that screening results consistent with new diabetes diagnosis require prompt referral for comprehensive medical management, not watchful waiting.

Question 7

1. Recommend live-attenuated vaccines (e.g., live zoster vaccine) preferentially because biologics improve vaccine response
2. Review immunization status and recommend indicated inactivated vaccines (e.g., influenza annually, pneumococcal, recombinant zoster) while avoiding live vaccines during immunosuppressive therapy (correct answer)
3. Defer all vaccines indefinitely because any vaccination is contraindicated with methotrexate
4. Recommend tetanus booster every 6 months due to immunosuppression

Explanation: This question tests the concept of immunization recommendations in immunocompromised patients on biologics and immunosuppressants. The key patient-specific factor is the use of adalimumab and methotrexate for rheumatoid arthritis, contraindicating live vaccines due to infection risk. Choice B is the best action because reviewing status and recommending inactivated vaccines like influenza, pneumococcal, and recombinant zoster is appropriate. Choice A is incorrect as live vaccines are avoided in immunosuppression; choice C is wrong because inactivated vaccines are safe and recommended. Choice D is suboptimal as tetanus boosters are every 10 years, not 6 months. A clinical pearl is to vaccinate prior to starting immunosuppressants when possible. Avoid live vaccines during biologic therapy to prevent disseminated infection.

Question 8

1. Recommend levonorgestrel 1.5 mg single dose as the preferred option because enzyme inducers increase its effectiveness
2. Recommend ulipristal acetate 30 mg because it is unaffected by carbamazepine
3. Recommend a copper intrauterine device referral as the most effective emergency contraception option with carbamazepine use (correct answer)
4. Recommend no emergency contraception because carbamazepine provides pregnancy protection

Explanation: This question tests the concept of emergency contraception selection in the context of drug interactions with enzyme inducers. The key patient-specific factor is the use of carbamazepine, a strong CYP3A4 inducer that reduces efficacy of hormonal emergency contraceptives like levonorgestrel or ulipristal. Choice C is the best action because recommending copper IUD referral provides the most effective option unaffected by inducers. Choice A is incorrect as enzyme inducers decrease, not increase, levonorgestrel effectiveness; choice B is wrong because ulipristal is also affected by inducers. Choice D is suboptimal as carbamazepine does not provide contraception. A transferable pearl is that non-hormonal methods like copper IUD are preferred with enzyme inducers. Counsel on consistent contraception use to prevent unintended pregnancies.

Question 9

1. Document this as a true IgE-mediated penicillin allergy and recommend lifelong avoidance of all beta-lactams
2. Clarify and document the reaction as likely intolerance and recommend referral for penicillin allergy evaluation/testing if future beta-lactam therapy is needed (correct answer)
3. Recommend immediate epinephrine auto-injector prescription due to the reported nausea/diarrhea with amoxicillin
4. Recommend clindamycin for any future infection because it is always safer in patients with any penicillin reaction

Explanation: This question tests the concept of evaluating reported drug allergies, distinguishing true hypersensitivity from intolerance, and recommending appropriate follow-up. The key patient-specific factor is the childhood reaction to amoxicillin limited to nausea and diarrhea without signs of IgE-mediated allergy like rash or anaphylaxis. Choice B is the best action because clarifying the reaction as likely intolerance and recommending evaluation allows safe future beta-lactam use if needed. Choice A is incorrect as nausea/diarrhea does not indicate true IgE allergy requiring lifelong avoidance; choice C is unnecessary as the reaction does not suggest anaphylaxis needing epinephrine. Choice D is suboptimal because clindamycin is not always safer and has its own risks like Clostridioides difficile. A transferable pearl is that many reported penicillin allergies are not true hypersensitivities, and delabeling can improve antibiotic stewardship. Pharmacists should document reaction details to guide future therapy decisions.

Question 10

1. Reassure the patient that HbA1c of 7.4% is normal and repeat screening in 3 years
2. Recommend confirmatory evaluation for diabetes (e.g., repeat fasting plasma glucose or HbA1c) and prompt primary care follow-up to initiate therapy (correct answer)
3. Recommend a low-sodium diet only and recheck blood pressure in 6 months without addressing glucose results
4. Start over-the-counter insulin immediately without prescriber involvement due to the elevated HbA1c

Explanation: This question tests the clinical pharmacy concept of interpreting diabetes screening results and recommending appropriate follow-up based on diagnostic criteria. The key patient-specific factors are the elevated fasting plasma glucose of 146 mg/dL, HbA1c of 7.4%, and symptoms of polyuria and increased thirst for 2 months, indicating possible new-onset diabetes. Choice B is the best action because it recommends confirmatory testing and prompt primary care follow-up to initiate therapy, aligning with guidelines for diagnosing and managing diabetes to prevent complications. Choice A is incorrect because an HbA1c of 7.4% is diagnostic for diabetes and requires intervention, not reassurance; choice C is suboptimal as it ignores the glucose abnormalities and focuses only on hypertension. Choice D is inappropriate because starting over-the-counter insulin without prescriber involvement is unsafe and not evidence-based. A transferable clinical pearl is that symptomatic hyperglycemia with elevated screening tests warrants urgent evaluation to confirm diabetes and start management. Pharmacists should always emphasize lifestyle modifications alongside medical therapy in such cases.

Question 11

1. Advise that acid-reducing agents can decrease rilpivirine absorption; separate famotidine dosing appropriately or consult prescriber for alternative reflux management (correct answer)
2. Advise taking famotidine at the same time as rilpivirine to improve antiretroviral absorption
3. Advise stopping antiretroviral therapy when taking heartburn medications to prevent interactions
4. Advise switching to omeprazole 40 mg daily because proton pump inhibitors are preferred with rilpivirine

Explanation: This question tests the concept of drug interactions affecting antiretroviral absorption, specifically acid reducers with rilpivirine. The key patient-specific factor is the new OTC famotidine with rilpivirine, where acid suppression can decrease rilpivirine bioavailability and efficacy. Choice A is the best counseling because advising separation or alternatives prevents virologic failure. Choice B is incorrect as same-time dosing worsens the interaction; choice C is wrong because stopping ART is harmful. Choice D is suboptimal as PPIs like omeprazole are contraindicated with rilpivirine. A transferable pearl is that rilpivirine requires gastric acidity for absorption. Always check OTC additions for ART interactions.

Question 12

1. Advise the patient to start all three diabetes agents today without contacting anyone to avoid hyperglycemia
2. Instruct the patient to stop metformin immediately because eGFR is 32 mL/min/1.73 m$^2$ and metformin is always contraindicated below 60
3. Contact the discharging team/primary care office to clarify the intended diabetes regimen and verify whether insulin and glipizide were newly prescribed before the patient starts them (correct answer)
4. Recommend switching glipizide to glyburide due to better kidney safety at eGFR 32 mL/min/1.73 m$^2$

Explanation: This question tests the concept of medication reconciliation post-hospital discharge, focusing on verifying new prescriptions and assessing renal safety of diabetes medications. The key patient-specific factor is the patient's report of only prior use of metformin and a 'blue pill,' with new additions of glipizide and insulin glargine, alongside an eGFR of 32 mL/min/1.73 m² indicating CKD stage 3. Choice C is the best action because contacting the discharging team ensures clarification of the intended regimen and verifies if these were appropriately prescribed, preventing potential errors. Choice A is incorrect as starting all agents without verification risks harm; choice B is wrong because metformin is contraindicated below eGFR 30, but at 32 it may be continued with caution, not immediately stopped. Choice D is suboptimal as glyburide has higher hypoglycemia risk in CKD compared to glipizide. A clinical pearl is to always perform thorough reconciliation post-discharge to catch discrepancies. For CKD patients, prefer diabetes agents like glipizide or insulin that are safer in reduced renal function.

Question 13

1. Recommend a structured plan targeting 5%–10% weight loss through calorie reduction and at least 150 minutes/week of moderate-intensity activity (correct answer)
2. Recommend replacing meals with stimulant-containing supplements to accelerate weight loss
3. Recommend avoiding all carbohydrates permanently as the only effective approach for prediabetes
4. Recommend delaying lifestyle changes until HbA1c is at least 7.0%

Explanation: This question tests the concept of lifestyle interventions for obesity and prediabetes to prevent progression to diabetes. The key patient-specific factor is the patient's obesity (76 kg), prediabetes (HbA1c 6.1%), and habits like sugary drinks and sedentary lifestyle. Choice A is the best recommendation because targeting 5-10% weight loss via diet and 150 min/week activity is evidence-based for prediabetes management. Choice B is incorrect as stimulant supplements are unsafe and not recommended; choice C is wrong because extreme carb avoidance is unsustainable. Choice D is suboptimal as delaying changes until HbA1c 7.0% misses prevention opportunity. A transferable pearl is that modest weight loss can reduce diabetes risk by 58% in prediabetes. Tailor plans to patient barriers for better adherence.

Question 14

1. Recommend establishing care for confirmatory blood pressure evaluation and cardiovascular risk assessment, and begin lifestyle counseling immediately (correct answer)
2. Recommend starting over-the-counter nifedipine for immediate blood pressure control
3. Recommend repeating blood pressure screening in 5 years because a single elevated reading is sufficient to diagnose hypertension
4. Recommend treating headaches with higher-dose ibuprofen to reduce blood pressure related to pain

Explanation: This question tests the concept of follow-up after elevated blood pressure screening in undiagnosed individuals. The key patient-specific factor is the single elevated reading of 152/94 mmHg with no primary care, plus risk factors like alcohol and ibuprofen use. Choice A is the best action because recommending care establishment for confirmation and risk assessment, with lifestyle counseling, follows guidelines. Choice B is incorrect as OTC nifedipine is not appropriate self-treatment; choice C is wrong because a single reading requires confirmation, not 5-year delay. Choice D is suboptimal as higher ibuprofen could worsen hypertension. A clinical pearl is that hypertension diagnosis needs multiple readings. Initiate lifestyle advice early to mitigate risks.

Question 15

1. Recommend ibuprofen 600 mg by mouth three times daily with food because it is safer than acetaminophen in peptic ulcer disease
2. Recommend acetaminophen up to 3000 mg/day as needed and avoid nonsteroidal anti-inflammatory drugs due to prior gastrointestinal bleed and naproxen allergy history (correct answer)
3. Recommend naproxen 500 mg by mouth twice daily because aspirin provides gastrointestinal protection
4. Recommend adding clopidogrel 75 mg daily to reduce pain-related inflammation and protect the heart

Explanation: This question tests safe analgesic selection considering contraindications and drug allergies. The patient has multiple NSAID contraindications: prior GI bleed, current aspirin use, documented NSAID allergy (naproxen), and regular alcohol use. Option B is correct because acetaminophen is the safest option, though limited to 3000 mg/day due to regular alcohol intake, and NSAIDs must be avoided given his risk factors and allergy history. Option A is contraindicated due to GI bleed history and concurrent aspirin. Option C is absolutely contraindicated due to documented naproxen allergy (hives and angioedema indicate IgE-mediated reaction). Option D is incorrect as clopidogrel is an antiplatelet without analgesic properties and would increase bleeding risk. The key principle is that patients with NSAID allergies and GI bleeding history should use acetaminophen as first-line analgesia, with dose adjustment for alcohol use.

Question 16

1. Recommend a once-daily routine with a pillbox and phone reminders, and assess barriers contributing to missed hydrochlorothiazide doses (correct answer)
2. Recommend stopping hydrochlorothiazide and using ibuprofen as needed to control blood pressure
3. Recommend taking hydrochlorothiazide only on days when blood pressure feels high to reduce pill burden
4. Recommend switching to twice-daily hydrochlorothiazide dosing to improve adherence

Explanation: This question tests the concept of improving medication adherence in hypertension management, addressing barriers like missed doses and lifestyle factors. The key patient-specific factor is the patient's admission of missing 2-3 hydrochlorothiazide doses per week, contributing to uncontrolled blood pressure of around 160/97 mmHg. Choice A is the best strategy because recommending a once-daily routine with tools like pillboxes and reminders directly targets adherence barriers. Choice B is incorrect as stopping HCTZ and using ibuprofen could worsen blood pressure and cause harm; choice C is wrong because PRN use of antihypertensives is ineffective. Choice D is suboptimal as twice-daily dosing may further reduce adherence. A transferable pearl is to assess adherence using open-ended questions and offer practical tools. Always address modifiable factors like high-sodium diet or caffeine in hypertension counseling.

Question 17

1. Assess and update vaccines recommended for asplenia (e.g., pneumococcal, meningococcal, Haemophilus influenzae type b) and ensure annual influenza vaccination (correct answer)
2. Recommend human papillomavirus vaccination only if she is older than 45 years
3. Defer all vaccines because asthma is a contraindication to inactivated vaccines
4. Recommend shingles (recombinant zoster) vaccination now because it is routinely indicated for all adults younger than 30

Explanation: This question tests the concept of immunization recommendations for patients with functional asplenia, focusing on vaccines to prevent encapsulated bacterial infections. The key patient-specific factor is the history of splenectomy at age 20, increasing risk for infections like pneumococcus and meningococcus, despite her young age. Choice A is the best action because assessing and updating asplenia-specific vaccines, including annual influenza, is crucial for prevention. Choice B is incorrect as HPV vaccine is routinely recommended up to age 26, not specifically if older than 45; choice C is wrong because asthma is not a contraindication to inactivated vaccines. Choice D is suboptimal as recombinant zoster vaccine is indicated for adults 50+ or immunocompromised, not routinely for those under 30. A transferable pearl is that asplenic patients require lifelong vaccination against encapsulated organisms. Use tools like the CDC app to tailor immunization plans based on medical history.

Question 18

1. Recommend initiating age-appropriate colorectal cancer screening now (e.g., stool-based test or colonoscopy) and coordinate referral to primary care/gastroenterology (correct answer)
2. Recommend delaying colorectal cancer screening until age 75 because he has no family history
3. Recommend colorectal cancer screening only if he develops gastrointestinal symptoms
4. Recommend annual colonoscopy for all adults with diabetes regardless of age or risk factors

Explanation: This question assesses knowledge of evidence-based colorectal cancer screening guidelines, particularly for patients with comorbidities like diabetes. The key patient-specific factors are the patient's age of 65 years, lack of prior screening, and presence of type 2 diabetes, which may slightly elevate colorectal cancer risk but does not alter standard screening initiation. Choice A is the best recommendation because USPSTF guidelines advise starting colorectal cancer screening between ages 45-50 and continuing until age 75 for average-risk individuals, with options like stool-based tests or colonoscopy being appropriate now given his age and unscreened status. Choice B is incorrect as delaying until age 75 would miss the recommended screening window and increase risk of undetected disease; choice C is suboptimal because screening is preventive and should not wait for symptoms, which often indicate advanced disease; choice D is excessive as annual colonoscopies are not standard for diabetic patients without high-risk factors like family history or prior polyps. A transferable clinical pearl is that diabetes is associated with higher colorectal cancer incidence, underscoring the importance of adhering to screening timelines in this population. A decision framework for screening involves assessing age, risk factors (e.g., family history, comorbidities), and patient preferences to select modalities like non-invasive stool tests for those hesitant about colonoscopy.

Question 19

1. Recommend initiating moderate- to high-intensity statin therapy discussion with her prescriber due to diabetes and elevated LDL-C (correct answer)
2. Recommend niacin monotherapy as first-line because it raises HDL-C
3. Recommend repeating the lipid panel in 10 years because screening is only needed once per decade
4. Recommend stopping amlodipine because it is the most common cause of elevated LDL-C

Explanation: This question tests the concept of lipid management in patients with diabetes, using guidelines for statin initiation based on cardiovascular risk. The key patient-specific factor is the presence of type 2 diabetes with elevated LDL-C of 171 mg/dL and uncontrolled HbA1c of 7.9%, placing her in a high-risk category warranting statin therapy. Choice A is the best action because recommending discussion for moderate- to high-intensity statin aligns with guidelines to reduce ASCVD risk. Choice B is incorrect as niacin is not first-line and has limited efficacy/safety; choice C is wrong because repeat screening should be sooner in high-risk patients, not every 10 years. Choice D is suboptimal as amlodipine does not commonly cause elevated LDL-C. A clinical pearl is that adults with diabetes aged 40-75 should receive at least moderate-intensity statin regardless of baseline LDL-C. Incorporate shared decision-making when recommending lipid therapy.

Question 20

1. Recommend switching omeprazole to pantoprazole (or using an H2-receptor antagonist if appropriate) due to reduced clopidogrel activation with omeprazole (correct answer)
2. Recommend doubling clopidogrel to 150 mg daily to overcome the interaction without changing acid suppression therapy
3. Recommend stopping rosuvastatin because statins reduce clopidogrel effectiveness
4. Recommend taking clopidogrel at bedtime and omeprazole in the morning to completely eliminate the interaction

Explanation: This question tests the concept of identifying drug-drug interactions, specifically CYP2C19 inhibition by proton pump inhibitors affecting clopidogrel efficacy. The key patient-specific factor is the recent self-initiation of omeprazole 40 mg daily with clopidogrel, potentially reducing clopidogrel activation and increasing thrombotic risk post-stent. Choice A is the best recommendation because switching to pantoprazole or an H2-antagonist minimizes the interaction while maintaining acid suppression. Choice B is incorrect as doubling clopidogrel is not standard and may increase bleeding risk; choice C is wrong because statins like rosuvastatin do not significantly reduce clopidogrel effectiveness. Choice D is suboptimal as timing separation does not fully eliminate the CYP-mediated interaction. A clinical pearl is to prefer pantoprazole or ranitidine with clopidogrel when PPI therapy is needed. Always assess self-started OTC medications for interactions in high-risk patients.